Gene · 84433
Papers2,534
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,534
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Variant scoring tools for deep mutational scanning. | Mol Syst Biol | 2025 | 40781375 | PubTator, text mining | PubMed |
| Loss of MALT1 Function in a Patient With Combined Immunodeficiency: a Novel Pathogenic Variant and Immunological Insights. | J Clin Immunol | 2025 | 40748513 | PubTator, text mining | PubMed |
| β-Actin Deficiency in Baraitser-Winter Syndrome Type 1 Disrupts T-Cell Function and Immune Regulation: Implications for Targeted Therapy in Actinopathies. | J Clin Immunol | 2025 | 40748410 | PubTator, text mining | PubMed |
| A multi-omics approach reveals dysregulated TNF-related signaling pathways in circulating NK and T cell subsets of young children with autism. | Genes Immun | 2025 | 40739030 | PubTator, text mining | PubMed |
| Genetic Landscape of Non-Remitting Neutropenia in Children and Chronic Idiopathic Neutropenia in Adults. | Int J Mol Sci | 2025 | 40725177 | PubTator, text mining | PubMed |
| Breaking the oncogenic link: BCL10-MALT1 disruption as a precision strike against NF-κB-driven lymphomas. | Med Oncol | 2025 | 40684038 | PubTator, text mining | PubMed |
| Integrated histomolecular approach to discriminate primary cutaneous follicle centre and marginal zone lymphoma of the scalp. | Pathology | 2025 | 40681458 | PubTator, text mining | PubMed |
| Identification of prognosis and therapy related intratumoral microbiome and immune signatures in gastric cancer. | Front Immunol | 2025 | 40677704 | PubTator, text mining | PubMed |
| From syndromic clues to diagnosis: understanding CARD11-driven disorders. | Front Immunol | 2025 | 40625738 | PubTator, text mining | PubMed |
| Network toxicology and immune-metabolic dysregulation: linking per- and polyfluoroalkyl substances exposure to osteoarthritis pathogenesis. | Toxicol Res (Camb) | 2025 | 40585420 | PubTator, text mining | PubMed |
| CARD11 signaling regulates CD8+ T cell tumoricidal function. | Nat Immunol | 2025 | 40533509 | PubTator, text mining | PubMed |
| Identifying the genomic landscape of EGFR-mutant lung cancers with central nervous system metastases. | Ann Oncol | 2025 | 40532851 | PubTator, text mining | PubMed |
| Expanding the phenotypic and genetic landscape of congenital neutropenia through whole-exome and genome sequencing. | Hemasphere | 2025 | 40510848 | PubTator, text mining | PubMed |
| Clinical outcomes of newly diagnosed PCNSL treated with rituximab-methotrexate-cytarabine with or without ibrutinib: a retrospective study. | Front Immunol | 2025 | 40475774 | PubTator, text mining | PubMed |
| A highly selective and orally bioavailable casein kinase 1 alpha degrader through p53 signaling pathway targets B-cell lymphoma cells. | Leukemia | 2025 | 40425803 | PubTator, text mining | PubMed |
| Analysis of significance of CARD11 and MYO1G expressions in pulmonary tuberculosis and their predictive value for prognosis of recurrence. | J Med Biochem | 2025 | 40386529 | PubTator, text mining | PubMed |
| A novel CARD11 heterozygous missense variant in a CADINS patient. | J Allergy Clin Immunol Glob | 2025 | 40275935 | PubTator, text mining | PubMed |
| A small-molecule inhibitor of BCL10-MALT1 interaction abrogates progression of diffuse large B cell lymphoma. | J Clin Invest | 2025 | 40231473 | PubTator, text mining | PubMed |
| Integrating genomic features for prognosis in Chinese patients with B-cell lymphoma following chimeric antigen receptor T-cell therapy. | Sci China Life Sci | 2025 | 40189492 | PubTator, text mining | PubMed |
| BENTA disease or CARD11 gain-of-function? A novel variant with atypical features and a literature review. | Immunol Lett | 2025 | 40157432 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/84433/papers?page=4